Related Experiment Video
Updated: Jun 13, 2025

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
Published on: February 28, 2025
Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain.
Juan Pablo Cerutti1,2, Lucas Abreu Diniz3, Viviane Corrêa Santos3
1Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA-CONICET), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba (FCQ-UNC), Haya de la Torre y Medina Allende, Córdoba 5000, Argentina.
Researchers developed novel triazole compounds targeting cruzipain (CZP), a key enzyme in Chagas disease. One compound, Ald-6, shows potent anti-parasitic activity and low toxicity, making it a promising candidate for further drug development.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Computational Chemistry
Background:
- Cruzipain (CZP) is a critical cysteine protease in *T. cruzi*, the parasite causing Chagas disease.
- Targeting CZP with inhibitors is a promising therapeutic strategy for Chagas disease.
- Developing effective inhibitors requires exploring diverse chemical spaces and ensuring biological activity translation.
Purpose of the Study:
- To design and identify novel 1,4-disubstituted 1,2,3-triazole analogues as potential targeted covalent inhibitors (TCIs) of cruzipain (CZP).
- To evaluate the synthesized compounds for their ability to inhibit CZP and exhibit anti-*T. cruzi* activity.
- To identify lead compounds for further preclinical development against Chagas disease.
Main Methods:
- Computer-aided drug design (CADD) including virtual screening of a large library (>75,000 analogues) using molecular docking and dynamics simulations.
- Combinatorial synthesis of selected candidates via Copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC).
- In vitro enzymatic assays for CZP inhibition (IC50 determination) and anti-*T. cruzi* activity, alongside cytotoxicity assessments.
Main Results:
- A virtual library of over 75,000 triazole analogues was screened, leading to 48 candidates for synthesis.
- Twelve synthesized compounds selectively inhibited CZP with IC50 values in the low micromolar range.
- Four derivatives demonstrated significant anti-*T. cruzi* activity at 50 μM, with Ald-6 showing excellent efficacy and low cytotoxicity.
- Ald-6 exhibited complete in vitro activity translation from CZP inhibition to anti-parasitic effect.
Conclusions:
- The study successfully identified potent triazole-based CZP inhibitors with significant anti-*T. cruzi* activity.
- Ald-6 is a promising lead compound for Chagas disease treatment, warranting further preclinical investigation.
- The explored chemical space of 1,2,3-triazoles represents a valuable resource for discovering novel antichagasic agents.
More Related Videos
10:58Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Protein-protein Interfaces